From 2D to 3D: development of monolayer dopaminergic neuronal and midbrain organoid cultures for Parkinson's disease modeling and regenerative therapy

Parkinson's Disease (PD) is a prevalent neurodegenerative disorder that is characterized pathologically by the loss of A9-specific dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc) of the midbrain. Despite intensive research, the etiology of PD is currently unresolved, and...

Full description

Saved in:
Bibliographic Details
Main Authors: Yeap, Yee Jie, Tng, Teddy J. W., Lee, Mok Jung, Goh, Micaela, Lim, Kah-Leong
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Article
Language:English
Published: 2023
Subjects:
Online Access:https://hdl.handle.net/10356/165606
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-165606
record_format dspace
spelling sg-ntu-dr.10356-1656062023-04-09T15:36:17Z From 2D to 3D: development of monolayer dopaminergic neuronal and midbrain organoid cultures for Parkinson's disease modeling and regenerative therapy Yeap, Yee Jie Tng, Teddy J. W. Lee, Mok Jung Goh, Micaela Lim, Kah-Leong Lee Kong Chian School of Medicine (LKCMedicine) Interdisciplinary Graduate School (IGS) National Neuroscience Institute Science::Medicine Parkinson’s Disease Pluripotent Stem Cells Parkinson's Disease (PD) is a prevalent neurodegenerative disorder that is characterized pathologically by the loss of A9-specific dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc) of the midbrain. Despite intensive research, the etiology of PD is currently unresolved, and the disease remains incurable. This, in part, is due to the lack of an experimental disease model that could faithfully recapitulate the features of human PD. However, the recent advent of induced pluripotent stem cell (iPSC) technology has allowed PD models to be created from patient-derived cells. Indeed, DA neurons from PD patients are now routinely established in many laboratories as monolayers as well as 3D organoid cultures that serve as useful toolboxes for understanding the mechanism underlying PD and also for drug discovery. At the same time, the iPSC technology also provides unprecedented opportunity for autologous cell-based therapy for the PD patient to be performed using the patient's own cells as starting materials. In this review, we provide an update on the molecular processes underpinning the development and differentiation of human pluripotent stem cells (PSCs) into midbrain DA neurons in both 2D and 3D cultures, as well as the latest advancements in using these cells for drug discovery and regenerative medicine. For the novice entering the field, the cornucopia of differentiation protocols reported for the generation of midbrain DA neurons may seem daunting. Here, we have distilled the essence of the different approaches and summarized the main factors driving DA neuronal differentiation, with the view to provide a useful guide to newcomers who are interested in developing iPSC-based models of PD. Ministry of Health (MOH) National Research Foundation (NRF) Published version This work was supported by grants from the Singapore National Research Foundation Competitive Research Program grant (NRF-CRP21-2018-0008) and the Singapore Ministry of Health Open Fund-Large Collaborative Grant (MOH-OFLCG18May-0002) awarded to K.L.L. 2023-04-03T08:13:50Z 2023-04-03T08:13:50Z 2023 Journal Article Yeap, Y. J., Tng, T. J. W., Lee, M. J., Goh, M. & Lim, K. (2023). From 2D to 3D: development of monolayer dopaminergic neuronal and midbrain organoid cultures for Parkinson's disease modeling and regenerative therapy. International Journal of Molecular Sciences, 24(3), 2523-. https://dx.doi.org/10.3390/ijms24032523 1661-6596 https://hdl.handle.net/10356/165606 10.3390/ijms24032523 36768843 2-s2.0-85147877332 3 24 2523 en NRF-CRP21-2018-0008 MOH-OFLCG18May-0002 International Journal of Molecular Sciences © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Science::Medicine
Parkinson’s Disease
Pluripotent Stem Cells
spellingShingle Science::Medicine
Parkinson’s Disease
Pluripotent Stem Cells
Yeap, Yee Jie
Tng, Teddy J. W.
Lee, Mok Jung
Goh, Micaela
Lim, Kah-Leong
From 2D to 3D: development of monolayer dopaminergic neuronal and midbrain organoid cultures for Parkinson's disease modeling and regenerative therapy
description Parkinson's Disease (PD) is a prevalent neurodegenerative disorder that is characterized pathologically by the loss of A9-specific dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc) of the midbrain. Despite intensive research, the etiology of PD is currently unresolved, and the disease remains incurable. This, in part, is due to the lack of an experimental disease model that could faithfully recapitulate the features of human PD. However, the recent advent of induced pluripotent stem cell (iPSC) technology has allowed PD models to be created from patient-derived cells. Indeed, DA neurons from PD patients are now routinely established in many laboratories as monolayers as well as 3D organoid cultures that serve as useful toolboxes for understanding the mechanism underlying PD and also for drug discovery. At the same time, the iPSC technology also provides unprecedented opportunity for autologous cell-based therapy for the PD patient to be performed using the patient's own cells as starting materials. In this review, we provide an update on the molecular processes underpinning the development and differentiation of human pluripotent stem cells (PSCs) into midbrain DA neurons in both 2D and 3D cultures, as well as the latest advancements in using these cells for drug discovery and regenerative medicine. For the novice entering the field, the cornucopia of differentiation protocols reported for the generation of midbrain DA neurons may seem daunting. Here, we have distilled the essence of the different approaches and summarized the main factors driving DA neuronal differentiation, with the view to provide a useful guide to newcomers who are interested in developing iPSC-based models of PD.
author2 Lee Kong Chian School of Medicine (LKCMedicine)
author_facet Lee Kong Chian School of Medicine (LKCMedicine)
Yeap, Yee Jie
Tng, Teddy J. W.
Lee, Mok Jung
Goh, Micaela
Lim, Kah-Leong
format Article
author Yeap, Yee Jie
Tng, Teddy J. W.
Lee, Mok Jung
Goh, Micaela
Lim, Kah-Leong
author_sort Yeap, Yee Jie
title From 2D to 3D: development of monolayer dopaminergic neuronal and midbrain organoid cultures for Parkinson's disease modeling and regenerative therapy
title_short From 2D to 3D: development of monolayer dopaminergic neuronal and midbrain organoid cultures for Parkinson's disease modeling and regenerative therapy
title_full From 2D to 3D: development of monolayer dopaminergic neuronal and midbrain organoid cultures for Parkinson's disease modeling and regenerative therapy
title_fullStr From 2D to 3D: development of monolayer dopaminergic neuronal and midbrain organoid cultures for Parkinson's disease modeling and regenerative therapy
title_full_unstemmed From 2D to 3D: development of monolayer dopaminergic neuronal and midbrain organoid cultures for Parkinson's disease modeling and regenerative therapy
title_sort from 2d to 3d: development of monolayer dopaminergic neuronal and midbrain organoid cultures for parkinson's disease modeling and regenerative therapy
publishDate 2023
url https://hdl.handle.net/10356/165606
_version_ 1764208166880411648